- Forums
- ASX - By Stock
- MSB
- Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
MSB
mesoblast limited
Add to My Watchlist
0.00%
!
$1.66

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-8
-
- There are more pages in this discussion • 368 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.66 |
Change
0.000(0.00%) |
Mkt cap ! $2.114B |
Open | High | Low | Value | Volume |
$1.65 | $1.67 | $1.63 | $1.378M | 835.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 15810 | $1.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.66 | 15543 | 31 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 4917 | 1.655 |
15 | 32246 | 1.650 |
19 | 133563 | 1.645 |
14 | 76088 | 1.640 |
17 | 165402 | 1.635 |
Price($) | Vol. | No. |
---|---|---|
1.660 | 20410 | 30 |
1.665 | 36820 | 21 |
1.670 | 68068 | 17 |
1.675 | 83793 | 9 |
1.680 | 68494 | 8 |
Last trade - 13.05pm 14/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |